| __timestamp | Ascendis Pharma A/S | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 5078000000 |
| Thursday, January 1, 2015 | 9415000 | 4717000000 |
| Friday, January 1, 2016 | 11504000 | 5096000000 |
| Sunday, January 1, 2017 | 13482000 | 4986000000 |
| Monday, January 1, 2018 | 25057000 | 4214000000 |
| Tuesday, January 1, 2019 | 48473000 | 3806000000 |
| Wednesday, January 1, 2020 | 76669000 | 3671000000 |
| Friday, January 1, 2021 | 160180000 | 3528000000 |
| Saturday, January 1, 2022 | 221227000 | 3445000000 |
| Sunday, January 1, 2023 | 264410000 | 3498000000 |
| Monday, January 1, 2024 | 284545000 | 3702000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S have showcased contrasting trends in their SG&A efficiency.
Teva, a well-established player, has seen a gradual reduction in SG&A expenses, dropping from approximately $5 billion in 2014 to around $3.5 billion in 2023. This represents a 30% decrease, reflecting strategic cost management. In contrast, Ascendis Pharma, a rising star, has experienced a significant increase in SG&A expenses, from $6 million in 2014 to $264 million in 2023, marking a staggering 4,100% rise. This surge indicates aggressive expansion and investment in growth.
These trends highlight the diverse strategies employed by pharmaceutical companies to navigate market challenges and opportunities.
Eli Lilly and Company and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Ascendis Pharma A/S
Vertex Pharmaceuticals Incorporated or Ascendis Pharma A/S: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of GSK plc and Teva Pharmaceutical Industries Limited
Operational Costs Compared: SG&A Analysis of GSK plc and Ascendis Pharma A/S
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited and Merus N.V.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Veracyte, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited and Geron Corporation: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Biogen Inc. and Ascendis Pharma A/S
Ascendis Pharma A/S and Pharming Group N.V.: SG&A Spending Patterns Compared